Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about INCY
Recent news which mentions INCY
< Previous
1
2
3
4
5
6
7
Next >
Incyte Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
March 12, 2024
Tickers
INCY
Tags
BZI/AAR
Benzinga
Analyst Ratings
From
Benzinga
Penny Stock Detox: 3 Stocks to Buy for Multibagger Returns Instead
March 11, 2024
Tickers
AAPL
ALB
AMZN
GSK
Tags
AAPL
Stocks to Buy
SHOP
From
InvestorPlace
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
March 07, 2024
Tickers
GSK
ILMN
INCY
MOR
Tags
MRK
ILMN
Market News
From
InvestorPlace
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
February 26, 2024
Tickers
ARCT
INCY
JAZZ
OCUP
Tags
VCYT
NASDAQ:INCY,NASDAQ:UTHR,NASDAQ:JAZZ,NASDAQ:VCYT,NASDAQ:ARCT,NASDAQ:VYGR,NASDAQ:OCUP
VYGR
From
InvestorPlace
Exit Now! 3 Biotech Stocks to Sell in February 2024
February 21, 2024
Tickers
INCY
MOR
NVS
SAVA
Tags
Market News
NASDAQ:NVAS,NASDAQ:SAVA,NASDAQ:INCY,NYSE:NVS,NASDAQ:MOR
NVAS
From
InvestorPlace
The Analyst Verdict: Incyte In The Eyes Of 8 Experts
February 14, 2024
Tickers
INCY
Tags
BZI/AAR
Benzinga
Analyst Ratings
From
Benzinga
Earnings Scheduled For February 13, 2024
February 13, 2024
Tickers
ABNB
ADC
AIG
AKAM
Tags
ZG
ABNB
NRC
From
Benzinga
Novartis Agrees To Acquire German Blood Cancer-Drug Developer MorphoSys For €2.7B
February 06, 2024
Tickers
INCY
MOR
NEWS
NVS
Tags
Health Care
Large Cap
Biotech
From
Benzinga
Why Is MorphoSys (MOR) Stock Up 50% Today?
February 05, 2024
Tickers
INCY
MOR
NVS
Tags
Market News
NASDAQ:MOR,NYSE:NVS,NASDAQ:INCY
NVS
From
InvestorPlace
MorphoSys Stock Soars After Report Says Novartis To Acquire Cancer-Drug Developer
February 05, 2024
Tickers
INCY
MOR
NEWS
NVS
Tags
Benzinga
Market News
MOR
From
Benzinga
3 Pharma Stocks Could Be the Pills Your Portfolio Needs
January 18, 2024
Tickers
EXEL
INCY
PFE
SGEN
Tags
INCY
NYSE:PFE,NASDAQ:SGEN,NASDAQ:INCY,NASDAQ:EXEL
PFE
From
InvestorPlace
Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations
January 10, 2024
Tickers
ACRS
INCY
NEWS
ROIV
Tags
Penny Stocks
Benzinga
Analyst Ratings
From
Benzinga
AI Meets Biotech: 3 Top Stocks Transforming Medical Science
December 16, 2023
Tickers
ABCL
BAYRY
DNA
GOOG
Tags
Expert Stock Picks
REGN
PRLD
From
InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in December
December 15, 2023
Tickers
INCY
KNSA
NBIX
RHHBY
Tags
INCY
NBIX
KNSA
From
InvestorPlace
Expert Ratings for Incyte
December 13, 2023
Tickers
INCY
Tags
BZI/AAR
Benzinga
Analyst Ratings
From
Benzinga
What's Up With Incyte Stock Lately?
December 12, 2023
Tickers
INCY
Tags
Benzinga
Market News
Movers
From
Benzinga
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
December 07, 2023
Tickers
ALB
ALGN
ALK
APA
Tags
Trading Ideas
BWA
UAL
From
Benzinga
Goldman Sachs Downgrades Incyte Amid Concerns Over Jakafi Studies, Competitiveness
November 21, 2023
Tickers
INCY
Tags
Benzinga
Trading Ideas
Analyst Ratings
From
Benzinga
The Latest Analyst Ratings for Incyte
November 21, 2023
Tickers
INCY
Tags
Market News
Analyst Ratings
INCY
From
Benzinga
3 Biotech Stocks That Are Poised to Have Breakthroughs in 2024
November 12, 2023
Tickers
CRSP
INCY
SWAV
Tags
SWAV
Market News
Stocks to Buy
From
InvestorPlace
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
November 09, 2023
Tickers
BNTX
CORT
GMAB
HALO
Tags
BNTX
REGN
GMAB
From
InvestorPlace
Goldman Sachs Maintains Buy Rating for Incyte: Here's What You Need To Know
November 02, 2023
Tickers
INCY
Tags
Benzinga
BZI/AAR/UPDATE
INCY
From
Benzinga
Earnings Outlook For Incyte
October 30, 2023
Tickers
INCY
Tags
Benzinga
INCY
BZI/EP
From
Benzinga
Quant Ratings Updated on 73 Stocks
September 26, 2023
Tickers
ABT
AWK
CL
CNI
Tags
STLA
GD
CL
From
InvestorPlace
Expert Ratings for Incyte
September 21, 2023
Tickers
INCY
Tags
Analyst Ratings
Market News
INCY
From
Benzinga
3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall
September 20, 2023
Tickers
EXEL
INCY
JAZZ
Tags
INCY
NASDAQ:JAZZ,NASDAQ:INCY,NASDAQ:EXEL
Stocks to Buy
From
InvestorPlace
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
September 18, 2023
Tickers
BMY
GSK
INCY
Tags
Analyst Color
Expert Ideas
Markets
From
Benzinga
Analyst Ratings for Incyte
August 02, 2023
Tickers
INCY
Tags
Market News
Analyst Ratings
INCY
From
Benzinga
Incyte's Jakafi Patent Expiry In 2028 Poses Challenge, Analyst Says New Treatments To Battle For Market Share
August 01, 2023
Tickers
INCY
Tags
Analyst Color
Expert Ideas
Guidance
From
Benzinga
Incyte's Earnings Outlook
July 31, 2023
Tickers
INCY
Tags
Benzinga
Market News
Earnings
From
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.